Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/3266
Title: | Novartis Access: a small step towards increased access for non-communicable disease care |
Authors: | Manji, Imran Pastakia, Sonak D |
Keywords: | Medication access Non-communicable disease |
Issue Date: | Feb-2019 |
Publisher: | Lancet Global health |
Abstract: | Pharmaceutical companies are often maligned for many of the limitations in medication access in low-income and middle-income countries. Furthermore, many of their efforts to support health-care delivery in these settings are viewed solely as efforts to improve public relations and are not typically subjected to the in-depth peer review that most health-care interventions receive before dissemination to the public. In The Lancet Global Health, Peter Rockers and colleagues1 present a necessary and timely evaluation of an industry-led initiative to improve medicine access, which helps to change this narrative and provides many lessons to others in the pharmaceutical industry who are embarking on similar access programmes. |
URI: | https://doi.org/10.1016/S2214-109X(19)30049-X http://ir.mu.ac.ke:8080/jspui/handle/123456789/3266 |
Appears in Collections: | School of Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.